科研之友ScholarMate
免费注册
首页 论文 论文详情
赞 收藏 引用

Alemtuzumab improves quality of life in relapsing-remitting multiple sclerosis patients with inadequate efficacy response to prior therapy: 4-year follow-up of CARE-MS II

作者：Arroyo Gonzalez R; Moreau T; Cohen J A; Giovannoni G; Margolin D H; Kasten L; Havrdova E
来源：1st Congress of the European-Academy-of-Neurology, 2015-06 to 2015-06.
收藏 分享 被引 浏览
更新时间：2017-09-14 19:46